Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Global Distraction Osteogenesis Devices Market, by Device Type (Mandibular Distraction Devices, Palatal Distraction Devices, Alveolar Distraction Devices, Cranial Distraction Devices, LeFort Distraction Devices, and Others), by Placement (Internal Distractors and External Distractors), by End User (Hospitals, Orthopedic Clinics, and Others) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 219.1 Million in 2017 and is projected to exhibit a CAGR of 4.7% over the forecast period (2017-2025), as highlighted in a new report published by Coherent Market Insights. The distraction osteogenesis devices market is expected to gain significant traction, owing to rising number of initiatives undertaken by organizations to create awareness about the available procedures and the launch of innovative computer assisted software.
Advancement in technology in distraction osteogenesis devices to augment growth of the market
Key players are focusing on research and development to introduce innovative products for enhancing patient satisfaction, procedure efficiency, and clinical outcomes, thus, increasing adoption of these technologically advanced devices leading to growth of the market. For instance, in October 2017, DePuy Synthes introduced MAXFRAME Multi-Axial Correction System, an external circular fixation device with a 3D planning software that helps improve accuracy of the deformity correction plan, which may reduce overall treatment time while improving procedural efficiency and reducing costs. The system is indicated for fracture fixation, limb lengthening, bone deformity correction in adults and children. Also, in 2013, DePuy Synthes—a subsidiary of Johnson & Johnson—launched TRUMATCH CMF Solutions for facial reconstruction, orthognathic surgery, distraction, and cranial reconstruction. CMF solution offers integrated approach for virtual surgical planning and fabrication of individualized implants for patients undergoing complex maxillofacial reconstructive procedures, thereby cutting treatment times and lowering costs.
Browse 36 Market Data Tables and 34 Figures spread through 183 Pages and in-depth TOC on "Distraction Osteogenesis Devices Market"- Global Forecast to 2025, by Device Type (Mandibular Distraction Devices, Palatal Distraction Devices, Alveolar Distraction Devices, Cranial Distraction Devices, LeFort Distraction Devices, and Others), by Placement (Internal Distractors and External Distractors), by End User (Hospitals, Orthopedic Clinics, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
To know the latest trends and insights prevalent in the distraction osteogenesis devices market, click the link below:
Distraction osteogenesis is an effective treatment option for correction of facial asymmetries and has successfully aided in rehabilitation of number of patients suffering from facial disfigurements. According to a study by researchers at Dalhousie University, 2012, the success rate in preventing tracheostomy was 91.3% in neonates and infants using mandibular distraction osteogenesis (MDO). The study also stated that MDO was proved to be highly efficient in alleviating upper airway obstruction in neonates, infants, and older children with Pierre Robin Sequence (PRS). Also, distraction osteogenesis eliminates the need for bone grafting by allowing surgeons with early intervention in pediatrics for speedy facial form and function restoration. This is expected to aid in growth of the market.
Moreover, increasing number of collaborations between manufacturers and scientists to develop innovative devices is a major factor augmenting the market growth. For instance, Europe-based company, Surgi-Tec collaborated with researchers at Brussels University Hospital, to enhance its product portfolio in jaw and facial surgery. Also, in 2017, Titamed collaborated with Royal Belgium Society of Stomatology and Maxillofacial Surgery and MKA Wassland and conducted an event with the European Association for Cranio Maxillo- Facial Surgery Congress in April 2018, to promote and showcase its range of products to maxillofacial surgeons, thus enhancing sales of its products in the market.
Key Takeaways of the Distraction Osteogenesis Devices Market:
The global distraction osteogenesis devices market is expected to exhibit a CAGR of 4.7% over the forecast period, owing to rising number of initiatives undertaken by the organizations to promote awareness about distraction osteogenesis and increasing incidence of the facial deformities
Among device type, palatal distraction devices segment holds a dominant position in the distraction osteogenesis devices market, owing to availability of a wide range of these devices and increasing incidence of cleft lip and palate among children.
Among placement, external distractors segment holds a dominant position in the distraction osteogenesis devices market, owing to fewer complications associated with external distractors and no requirement of undergoing second surgical procedure, which is mainly required in case of internal devices.
Among end user, hospitals segment is expected to be dominant in the distraction osteogenesis devices market, over the forecast period, owing to tailored pediatric treatments offered by hospitals using 3-D imaging and advanced software
Some of the major players operating in the global distraction osteogenesis devices market are Johnson & Johnson, Zimmer Biomet Holdings, Inc., Stryker Corporation, KLS Martin Group, Osteomed, Acumed LLC, and Titamed.